Global News

Greenphire appoints Claudine Paccio as chief operations officer

Monday, May 22, 2017

Greenphire, a global provider of automated clinical trial payment solutions, has appointed Claudine Paccio to the role of chief operations officer. Claudine comes to Greenphire with nearly three decades of experience building and leading global teams committed to operational excellence. In her role as chief operations officer, Claudine will oversee solution implementation and the ongoing success of Greenphire’s client partnerships.

[Read More]

All for one and one for all: A call for a Three Musketeers approach to online profiles

Monday, May 22, 2017

The Pulse on Technology by Elisa Cascade

We all know there is an issue surrounding investigator participation in industry-sponsored clinical trials. Tufts University puts the figure for doctors declining to return for a second study at approximately 40%. At the same time, the number of global clinical trials continues to rise and increase in complexity. We’ve all read articles and attended conferences that expound the passionate view that investigators who commit their time and expertise need our help and encouragement. But if that’s the case, why do we as an industry fail to address the administrative burdens driving them away?

[Read More]

IBM, Rensselaer Polytechnic Institute to research chronic diseases with cognitive computing

Friday, May 19, 2017

IBM and Rensselaer Polytechnic Institute announced the creation of the new Center for Health Empowerment by Analytics, Learning, and Semantics (HEALS). Located on the Rensselaer campus, the HEALS center is a five-year collaborative research effort aimed at researching how the application of advanced cognitive computing capabilities can help people to understand and improve their own health conditions.

[Read More]

Acurian launches consulting services for clinical trial enrollment planning

Friday, May 19, 2017

Acurian, a full-service provider of global patient enrollment and retention solutions and a subsidiary of Pharmaceutical Product Development (PPD), has launched a new consulting offering to aid pharmaceutical sponsors in advance strategic planning for clinical trials enrollment. Acurian Consulting Services provides patient-centric, data-driven insights that help drive protocol design, patient enrollment feasibility, site and country planning, CRO selection and budgeting for central recruitment.

[Read More]

Anthera screens first patient in pivotal Sollpura study

Wednesday, May 17, 2017

Anthera Pharmaceuticals has commenced screening in the RESULT phase III clinical study of Sollpura for exocrine pancreatic insufficiency due to cystic fibrosis. Based on feedback from the FDA, this non-inferiority study will compare the efficacy of Sollpura, a biologically manufactured pancreatic enzyme replacement therapy (PERT), to Pancreaze, a porcine-extracted PERT, as assessed by CFA after four weeks of treatment. Topline data are expected at the end of 2017 or early 2018, depending on the speed of patient enrollment.

[Read More]

AbbVie reported Imbruvica CLL/SLL data

Wednesday, May 17, 2017

AbbVie, a global biopharmaceutical company, announced results from an analysis of data pooled from three phase III studies evaluating Imbruvica (ibrutinib) use in patients with high-risk chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): RESONATE, RESONATE-2 and HELIOS.

[Read More]